Welcome to SynapCell
SynapCell is a preclinical Contract Research Organization which provides translational solutions to evaluate the therapeutic potential of CNS drug candidates in epilepsy. SynapCell provides customized solutions which cover the entire range of customers needs, from early steps to the final answer.
Services
In-vivo solutions
SynapCell assesses the effects of your drug candidates through predictive animal models of epilepsy, protocols mimicking clinical trials and quantitative results using EEG.
What's new
Antiepileptic Drug Trials XII Conference May 15-17 2013 Miami, Florida
SynapCell will present its Drug Discovery & Development solutions during the Anti-Epileptic Drugs and Device Trials
This is the twelfth conference focusing on issues related to antiepileptic drug (AED) development from preclinical discoveries through clinical evaluations. This symposium will bring together representatives from academia, industry, the NIH, and the FDA to review what has been learned and to discuss strategies to enhance AED development. It will take place in Miami from the 15th of May to the 17th.
SynapCell will be there to share with the different actors of Epilepsy and to present the MTLE Mouse as a tool for drug discovery and development. The presentation will take place Friday 17th during the morning in the congress room.
SynapCell will be happy to meet you there!
Feel free to contact us: +33 667 531 418 or cdumarest@synapcell.fr